These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 25299917)

  • 1. Biopharmaceutical benchmarks 2014.
    Walsh G
    Nat Biotechnol; 2014 Oct; 32(10):992-1000. PubMed ID: 25299917
    [No Abstract]   [Full Text] [Related]  

  • 2. Biopharmaceutical benchmarks 2018.
    Walsh G
    Nat Biotechnol; 2018 Dec; 36(12):1136-1145. PubMed ID: 30520869
    [No Abstract]   [Full Text] [Related]  

  • 3. Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry.
    Beck A; Reichert JM
    MAbs; 2013; 5(5):621-3. PubMed ID: 23924791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in capacity utilization for therapeutic monoclonal antibody production.
    Langer ES
    MAbs; 2009; 1(2):151-6. PubMed ID: 20061821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintaining 'standards' for biosimilar monoclonal antibodies.
    Prior S; Metcalfe C; Hufton SE; Wadhwa M; Schneider CK; Burns C
    Nat Biotechnol; 2021 Mar; 39(3):276-280. PubMed ID: 33664522
    [No Abstract]   [Full Text] [Related]  

  • 6. Study critiques corporate control of trials.
    Niiler E
    Nat Biotechnol; 2002 Dec; 20(12):1180. PubMed ID: 12454659
    [No Abstract]   [Full Text] [Related]  

  • 7. An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?
    Moorkens E; Vulto AG; Huys I
    MAbs; 2020; 12(1):1743517. PubMed ID: 32306833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical benchmarks--2003.
    Walsh G
    Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
    [No Abstract]   [Full Text] [Related]  

  • 9. First biosimilar drug approved for sale in the United States.
    Hede K
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142444
    [No Abstract]   [Full Text] [Related]  

  • 10. The state of biopharmaceutical manufacturing.
    Molowa DT; Mazanet R
    Biotechnol Annu Rev; 2003; 9():285-302. PubMed ID: 14650933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutical benchmarks 2010.
    Walsh G
    Nat Biotechnol; 2010 Sep; 28(9):917-24. PubMed ID: 20829826
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward biosimilar monoclonal antibodies.
    Schneider CK; Kalinke U
    Nat Biotechnol; 2008 Sep; 26(9):985-90. PubMed ID: 18779806
    [No Abstract]   [Full Text] [Related]  

  • 13. Fresh from the biotech pipeline-2018.
    Morrison C
    Nat Biotechnol; 2019 Feb; 37(2):118-123. PubMed ID: 30718867
    [No Abstract]   [Full Text] [Related]  

  • 14. Industry-sponsored clinical research: a double-edged sword.
    Montaner JS; O'Shaughnessy MV; Schechter MT
    Lancet; 2001 Dec; 358(9296):1893-5. PubMed ID: 11741648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First US biosimilar launch.
    Nat Biotechnol; 2015 Oct; 33(10):1013. PubMed ID: 26448071
    [No Abstract]   [Full Text] [Related]  

  • 16. Maturing biotechs turn to pharma's markets.
    Ratner M
    Nat Biotechnol; 2005 Mar; 23(3):269. PubMed ID: 15765067
    [No Abstract]   [Full Text] [Related]  

  • 17. Should platform companies move toward products?
    Ratner M
    Nat Biotechnol; 1999 Jan; 17(1):16-7. PubMed ID: 9920255
    [No Abstract]   [Full Text] [Related]  

  • 18. Advice for partnering with pharma.
    Howard K
    Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 20. 10 years of biosimilars: lessons and trends.
    Royzman I; Shah K
    Nat Rev Drug Discov; 2020 Jun; 19(6):375. PubMed ID: 32358591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.